These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19576971)

  • 1. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Toxicol Lett; 2009 Oct; 190(1):54-60. PubMed ID: 19576971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Biochem Pharmacol; 2009 Jun; 77(11):1725-34. PubMed ID: 19428327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Drug Metab Dispos; 2008 Nov; 36(11):2345-54. PubMed ID: 18725511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxyethylamphetamine and its single enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Drug Metab Dispos; 2009 Jun; 37(6):1152-6. PubMed ID: 19299523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
    Meyer MR; Maurer HH
    Chem Res Toxicol; 2009 Jun; 22(6):1205-11. PubMed ID: 19462939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
    Kumagai Y; Lin LY; Hiratsuka A; Narimatsu S; Suzuki T; Yamada H; Oguri K; Yoshimura H; Cho AK
    Mol Pharmacol; 1994 Feb; 45(2):359-65. PubMed ID: 7906857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regiochemical differences in cytochrome P450 isozymes responsible for the oxidation of methylenedioxyphenyl groups by rabbit liver.
    Kumagai Y; Lin LY; Philpot RM; Yamada H; Oguri K; Yoshimura H; Cho AK
    Mol Pharmacol; 1992 Oct; 42(4):695-702. PubMed ID: 1435745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiomer analysis of a new street drug, 3,4-methylenedioxy-N-methyl-butanamine, in rat urine.
    Nagai T; Matsushima K; Suzuki A; Saotome A; Kurosu A; Nihei H; Kuroyanagi K; Tokudome S
    J Anal Toxicol; 2002 Mar; 26(2):104-9. PubMed ID: 11916012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of methylenedioxyphenyl compounds by rabbit liver preparations. Participation of different cytochrome P450 isozymes in the demethylenation reaction.
    Kumagai Y; Wickham KA; Schmitz DA; Cho AK
    Biochem Pharmacol; 1991 Aug; 42(5):1061-7. PubMed ID: 1678603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)].
    Verweij AM
    Arch Kriminol; 1996; 197(1-2):27-30. PubMed ID: 8851250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
    Tucker G
    Hum Exp Toxicol; 1996 May; 15(5):455-7. PubMed ID: 8735473
    [No Abstract]   [Full Text] [Related]  

  • 12. CYP2B6, CYP2D6, and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomes.
    Davies BJ; Coller JK; Somogyi AA; Milne RW; Sallustio BC
    Drug Metab Dispos; 2007 Jan; 35(1):128-38. PubMed ID: 17050648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis.
    Cho AK; Hiramatsu M; Distefano EW; Chang AS; Jenden DJ
    Drug Metab Dispos; 1990; 18(5):686-91. PubMed ID: 1981721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users.
    Kronstrand R
    J Anal Toxicol; 1996 Oct; 20(6):512-6. PubMed ID: 8889691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes.
    Lin LY; Kumagai Y; Cho AK
    Chem Res Toxicol; 1992; 5(3):401-6. PubMed ID: 1354504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).
    Tucker GT; Lennard MS; Ellis SW; Woods HF; Cho AK; Lin LY; Hiratsuka A; Schmitz DA; Chu TY
    Biochem Pharmacol; 1994 Mar; 47(7):1151-6. PubMed ID: 7909223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
    Pizarro N; Farré M; Pujadas M; Peiró AM; Roset PN; Joglar J; de la Torre R
    Drug Metab Dispos; 2004 Sep; 32(9):1001-7. PubMed ID: 15319342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the mechanism of demethylenation of (methylenedioxy)phenyl compounds by cytochrome P450 using deuterium isotope effects.
    Fukuto JM; Kumagai Y; Cho AK
    J Med Chem; 1991 Sep; 34(9):2871-6. PubMed ID: 1680196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
    Kalasinsky KS; Hugel J; Kish SJ
    J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs.
    Kreth K; Kovar K; Schwab M; Zanger UM
    Biochem Pharmacol; 2000 Jun; 59(12):1563-71. PubMed ID: 10799653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.